In a sustainability survey of biopharma execs conducted by Cytiva and FT Longitude, 63% see sustainability as imperative to differentiation and business growth, while 64% said that failure to achieve sustainability targets poses a critical threat to their business.
Source: Cytiva report recommends strategy for achieving sustainability | Fierce Pharma
